Research Article
Prospective, Multicenter Evaluation of a Polyherbal Supplement alongside Standard-of-Care Treatment for Mild Knee Osteoarthritis
Table 2
Adverse events in the safety population (n = 137).
| Adverse event | N (%) N = 32 |
| Anemia | 6 (4.4) | Diarrhea/vomiting | 4 (2.9) | AST/ALT increase | 4 (2.9) | Increase in C-reactive protein | 3 (2.2) | Muscle stiffness/numbness | 3 (2.2) | Stomach pain | 3 (2.2) | Knee injury | 2 (1.6) | Upper respiratory tract infection | 2 (1.6) | Bloating | 1 (0.7) | Fracture of the right upper limb | 1 (0.7) | Leg swelling | 1 (0.7) | Leucopenia | 1 (0.7) | Sciatica | 1 (0.7) |
|
|
Including one serious adverse event. ALT: alanine transaminase; AST: aspartate transaminase; |